MedTrace Logo

STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program

NCT02825264 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2022-08-09

No results posted yet for this study

Summary

STARflo is a novel suprachoroidal Glaucoma Drainage Device (GDD), bleb-free, exhibiting anti-fibrotic properties. Release of this CE Marked implant has been limited to leading Glaucoma Centers in Europe.

Conditions

Interventions

DEVICE

STARflo Implant

All patients who have been implanted with STARflo implant from 2011 will be offered to participate to this data collection

Sponsors & Collaborators

  • iSTAR Medical

    lead INDUSTRY

Principal Investigators

  • Zubair Hussain, PhD · Sponsor Representative

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Belgium
  • France
  • Germany
  • Hungary
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02825264 on ClinicalTrials.gov